Tina is the Founder and President of Spindle. She has led the execution of over 50 consulting engagements, developing strategies for maximizing the value, effectiveness and downstream impact of academic, educational, commercial and advocacy programs powered by cutting-edge science. She has extensive experience in strategic planning, impact assessment, opportunity evaluation and capital sourcing and has worked with senior university leaders, industry executives and government decision makers on a wide range of strategy development projects.
For approximately 5 years before she founded Spindle, Tina served as the Director of Strategic Planning and Communications for Ontario Genomics, where she worked closely with senior government officials to develop strategic plans and implementation road maps aimed at bolstering Ontario’s innovation and commercialization capacity. Prior to her work at Ontario Genomics, Tina was a consultant with Shift Health, a boutique management consulting firm focused on the health sphere.
Tina received her Bachelor’s degree at the University of Waterloo and holds a Ph.D. in molecular mechanisms of infectious disease from the Department of Molecular Genetics at the University of Toronto.
Kathy is Spindle’s designated creative and technology expert. She brings 15+ years of experience in visual and digital arts. Kathy is a core team member on all of Spindle’s engagements, elevating virtually every aspect of our client-focused work. Kathy is experienced in stakeholder engagement and information gathering strategy, including the design and implementation of elaborate surveys and custom workshop experiences. She is a talented graphic designer with expertise in the simple communication of complex conceptual models. Kathy is proficient at large-scale quantitative data analysis and creative data visualization.
Rosemary is Spindle’s logistical and client services guru. She helps us to work in seamless partnership with our clients and to carry out extensive stakeholder engagement programs with a personal, mindful and client-centered touch. Rosemary holds a Bachelor of Arts in drama from Bishop’s University and is currently completing a second degree in Social Work at Ryerson University.
Anna Rose is Spindle’s Lead, Research and Learning. She has almost a decade of experience in research, evaluation and learning, specifically in the context of public health, economic development and job creation. She has worked with governments, academic and funding organizations in North America and globally, to help drive large-scale programs focused on health and social services, entrepreneurship, economic sustainability, and social inclusion. Her experience spans the evaluation of multi-dimensional funding and support programs on youth employment, examining access to HIV care, and researching the impact of COVID-19 on the economic viability of small businesses.
Previous to her work at Spindle, Anna Rose was a Manager with the Strategy and Learning team at the Mastercard Foundation in Toronto, where she oversaw a portfolio of multi-million dollar programs aimed at driving economic development and increasing youth employment through entrepreneurship.
Anna Rose brings deep cross-sectoral expertise in qualitative and survey research, including stakeholder engagement via focus groups, reflection sessions, and interactive workshops. She received a Bachelor’s degree in Anthropology and Psychology from McGill University and a Master’s of Public Health from the University of North Carolina at Chapel Hill, with a focus in Health Behaviour.
Tracy works with Spindle as a subject matter expert in health system planning. She has over 20 years of experience conducting healthcare capacity and delivery planning for many types of organizations including hospitals, home and community care organizations, primary care networks, community support services organizations, as well as for provincial and federal agencies. Tracy has extensive experience in the use of large datasets to estimate population needs for healthcare services, to evaluate healthcare gaps, to inform capacity planning and to improve quality and organizational performance. She has led large-scale research and analysis efforts including extensive benchmarking for hospitals and former CCACs, managed organizational and departmental strategy development, and conducted first of kind needs and capacity assessments for Mental Health and Addictions agencies in Ontario. Tracy has spent 11 years in the hospital sector in a variety of leadership roles including Program Business Manager and Manager of Decision Support. Most recently, she has worked with CHATS (Community Home Assistance to Seniors), Community Living Toronto, Four Villages Community Health Centre, Health Products Stewardship Association, Hemophilia Ontario, Ironshore Pharmaceuticals (subsidiary of Highland Therapeutics), Joint Centre for Bioethics at the University of Toronto, North York General Hospital, Ontario Chiropractic Association, Ontario Nurses Association and SPLC (Senior Persons Living Connected) to support capacity and financial planning. Tracy has a Bachelor of Arts and Science from McMaster University and a Masters in Health Administration from the University of British Columbia.
Alanna brings over 15 years of experience working in healthcare and public health in a wide variety of organizations and institutions in Canada and internationally. She has led large-scale research projects on patient safety, privacy of patient data, and innovation in clinical trials research. She has worked on collaborative teams investigating potential improvements in community and mental health education and outcomes. Alanna brings extensive experience in policy and governance, health and social science research, as well as advocacy, change management, and strategy development expertise in academic institutions, healthcare facilities, government organizations and non-profit settings.
She has worked as a consultant and in academic and advisory roles for prestigious initiatives in Canada, the United States, the United Kingdom, The Gambia and Rwanda. Alanna holds a Juris Doctor with a Specialization Certificate in Health Law and Policy from Dalhousie University’s Schulich School of Law, and a Master’s degree in Bioethics, Humanities and Society from Michigan State University where the focus of her research was ethical variability in clinical trials conducted in developed versus less developed nations.
Dr. Janet Rossant is an internationally recognized developmental and stem cell biologist who has led some of Canada’s most important scientific enterprises, including the research arm of SickKids Hospital in Toronto, where she is currently Senior Scientist and Chief of Research Emeritus, and the Gairdner Foundation, where she currently serves as President and Scientific Director.
As Chief of Research, Dr. Rossant set the strategic direction of the SickKids Research Institute from 2005 until 2015, and oversaw 2000 researchers and faculty. She raised $95 million in government funds and partnered with the SickKids Foundation to execute on the $200 million total budget to build and support the Peter Gilgan Centre for Research and Learning. Dr. Rossant presides over all fundraising, partnership development, adjudication, science diplomacy and community building activities of the Gairdner Foundation, one of the most prestigious scientific award organizations in the world.
With over 400 peer-reviewed publications, Dr. Rossant has made key contributions to our understanding of the early embryo and the role of stem cells in the nature and treatment of human disease. She also continues to lead key international ethics and public policy discussions around stem cell research and genetic modifications.
Dr. Rossant has received many honors and recognition for her work, including six honorary degrees, and election to the Royal Societies of London and Canada and the US National Academy of Sciences. In 2018 she received the N. American L’Oreal-UNESCO Women in Science Award and in 2021 the ISSCR Achievement Award. Dr. Janet Rossant was appointed a Companion of the Order of Canada in 2016 for advancing the global understanding of embryo development and stem cell biology, and for her national and international leadership in health science.
Mark J. Poznansky is the former CEO of Ontario Genomics – a provincial genomics-focused enabler – which he led from 2010 to 2017. During his tenure, he established the organization as a visionary and forward-thinking advocate for genomics-enabled technological and industrial transformation. He established a pioneering demand-pull model to facilitate the uptake of home-grown genomics innovations into local and global agriculture, water, mining, forestry and energy sectors and established mechanisms for securing millions in federal and industry funds in support of Ontario’s genomics research.
Previously he ran his own consultancy group offering a range of services including program reviews, strategic planning, change management and leadership training to clients in government, hospitals, universities and the private sector. He served as President and Scientific Director of Robarts Research Institute (London, Ontario) from 1993 to 2007, over which time the institute increased its staff from 100 to over 600, increased its annual research funding from $10 million to over $40 million, and developed a reputation for business development by spinning out seven different companies, including Viron Therapeutics, where Dr. Poznansky served as President and CEO. He has also served on the Merck USA Scientific Advisory Leadership Team, acted as Associate Dean of Medicine for Research at the University of Alberta and held faculty positions at the University of Western Ontario, University of Alberta and Harvard University.
Dr. Poznansky has published over 80 research papers. He has served as Chair of Let’s Talk Science, Chief Science Advisor to the CEO of the Thunder Bay Regional Research Institute and on the board of the Innovation Institute of Ontario. He was a founding member and past chair of the Council for Health Research in Canada, and chaired the Scientific Advisory Boards of the Canadian Medical Discoveries Fund and MDS Capital Corp. He has also served as a member of numerous science-related committees including the Science Advisory Committee of the Heart and Stroke Foundation of Canada and the Medical Research Council of Canada Grants panel. Dr. Poznansky was made a member of the Order of Ontario in 2004 and the Order of Canada in 2005.
Earning his bachelor’s degree and PhD at McGill University, Dr. Poznansky completed postdoctoral training at Harvard Medical School.
Dr. Maurice Bitran is a scientist, educator, public policy expert, and former public-sector executive. As CEO and Chief Science Officer of the Ontario Science Centre he led the organization to a renewed focus on public scientific literacy and presided over the Centre’s 50th anniversary celebrations in September 2019.
As an Assistant Deputy Minister in the Ontario Government, Maurice led the provincial portfolios on: Environmental Policy (including Climate Change and the Great Lakes); Economic Development Policy and Programs (including the Next Generation of Jobs Fund and the Advanced Manufacturing Investment Strategy); the Premier’s Jobs and Prosperity Council: and was Ontario’s Chief Negotiator for the Comprehensive Economic and Trade Agreement (CETA) with the European Union. He was also the Executive Director of the Ontario Research and Development Challenge Fund.
As a Senior Fellow at the Munk School of Global Affairs and Public Policy, Maurice teaches courses on policy implementation and the role of science in public policy. He has had academic appointments at the Faculty of Medicine of the University of Toronto, the Astronomy Department of the University of Florida, the Astronomy Department of the University of Chile, and at NASA’s Goddard Institute for Space Studies in New York City.
Maurice has served as a director in the Boards of the Association of Science and Technology Centres, Tourism Toronto, Ontario Genomics, and the Canadian Association of Science Centres.
A native of Chile, Maurice was selected as one of the Ten most influential Hispanic-Canadians in 2012, received the Public Service Award from Life Sciences Ontario in 2013, and the Leadership Award from the Transformation Institute for Leadership Innovation in 2019. He holds a Ph.D. in Astronomy from the University of Florida (USA) and is fluent in English, French, and Spanish.
George Ross is CEO and principal consultant at George Arthur Ross and Associates Inc and editor-in-chief of Canadian Government Executive magazine.
Mr. Ross has had a career spanning over 30 years in Public Service, including progressively more senior roles and an Assistant Deputy Minister appointment in the Ontario Ministry of Natural Resources. Mr. Ross has held the position of Deputy Minister with Ontario’s Ministries of Research and Innovation, Consumer Services and Northern Development and Mines as well as with Yukon Territory’s Department of Energy, Mines and Resources.
With the Ministry of Research and Innovation, Mr. Ross led the development of Ontario’s innovation network, oversaw the Ontario Research Fund, and led the establishment of Ontario’s Venture Capital Fund, the Emerging Technologies co-investment Fund, and the seed stage Investment Accelerator Fund to support venture capital investment in Ontario start-up companies.
Mr. Ross has extensive international experience in the area of trade and investment attraction, fostering international research collaborations and in public management and governance capacity building in developing countries.
He has served as President of the Institute of Public Administration of Canada (IPAC), Chair of the Ontario Capital Growth Corporation, co-Chair of the Conference Board of Canada’s Centre for the Advancement of Health Innovations and co-Chair of the Ontario Joint Committee on Science and Technology Cooperation with the People’s Republic of China. In addition, Mr. Ross has served on numerous boards including the Ontario Lottery and Gaming Corporation (OLG) and the Centre of Excellence in Mining Innovation (CEMI). He has received three awards from the Environmental Commissioner of Ontario and the 2012 Public Service Award from Life Sciences Ontario. He holds a Bachelor of Environmental Studies from the University of Waterloo and is a Board Director with the ICD.D designation from the Institute of Corporate Directors.